x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
20-8481962
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
Chaussée de la Hulpe 166
1170 Brussels, Belgium
|
|
|
|
|
|
2770 Research Drive
Rochester Hills, MI
|
|
48309-3511
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Large Accelerated Filer
|
|
x
|
|
Accelerated Filer
|
|
o
|
|
|
|
|
|||
Non-Accelerated Filer
|
|
o
|
(Do not check if a smaller reporting company)
|
Smaller Reporting Company
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
Emerging Growth Company
|
|
o
|
Common stock, $.01 par value, outstanding at
|
|
|
|
April 11, 2018
|
|
53,598,102
|
|
Contents
|
|
|
|
|
|
|
||
Item 1.
|
||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
|
||
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
Item 1.
|
||
Item 1A.
|
||
Item 2.
|
||
Item 6.
|
||
|
Item 1.
|
Financial Statements
|
|
Three Months Ended
March 31, |
||||||
(Amounts in millions, except share and per share data)
|
2018
|
|
2017
|
||||
Sales
|
$
|
1,003.3
|
|
|
$
|
747.3
|
|
Cost of sales
|
694.3
|
|
|
507.1
|
|
||
Gross profit
|
309.0
|
|
|
240.2
|
|
||
Operating expenses:
|
|
|
|
||||
Selling and administrative expenses
|
113.5
|
|
|
91.9
|
|
||
Research, development and engineering expenses
|
50.7
|
|
|
38.8
|
|
||
Other operating (income)/expense, net
|
(2.2
|
)
|
|
1.0
|
|
||
Operating income
|
147.0
|
|
|
108.5
|
|
||
Equity income of unconsolidated joint ventures, net
|
0.4
|
|
|
5.7
|
|
||
Other non-operating expense, net
|
(11.4
|
)
|
|
(10.7
|
)
|
||
Interest expense, net
|
(3.0
|
)
|
|
(3.9
|
)
|
||
Income before income taxes
|
133.0
|
|
|
99.6
|
|
||
Income tax expense
|
26.3
|
|
|
15.3
|
|
||
Net income including noncontrolling interests
|
106.7
|
|
|
84.3
|
|
||
Less: net income attributable to noncontrolling interests
|
6.0
|
|
|
3.6
|
|
||
Net income attributable to Company
|
$
|
100.7
|
|
|
$
|
80.7
|
|
Net income attributable to Company per common share
|
|
|
|
||||
Basic
|
$
|
1.87
|
|
|
$
|
1.49
|
|
Diluted
|
$
|
1.87
|
|
|
$
|
1.48
|
|
Cash dividends per share of common stock
|
$
|
—
|
|
|
$
|
—
|
|
Weighted average common shares outstanding
|
|
|
|
||||
Basic
|
53,740,732
|
|
|
54,299,058
|
|
||
Diluted
|
53,890,432
|
|
|
54,513,323
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
(Amounts in millions)
|
2018
|
|
2017
|
||||
Net income including noncontrolling interests
|
$
|
106.7
|
|
|
$
|
84.3
|
|
Other comprehensive income:
|
|
|
|
||||
Currency translation adjustments
|
23.7
|
|
|
36.5
|
|
||
Pension and post-retirement benefit plan adjustments, net
|
(3.2
|
)
|
|
1.9
|
|
||
Total other comprehensive income
|
$
|
20.5
|
|
|
$
|
38.4
|
|
Comprehensive income
|
$
|
127.2
|
|
|
$
|
122.7
|
|
Less: comprehensive income attributable to noncontrolling interests
|
5.1
|
|
|
6.3
|
|
||
Comprehensive income attributable to Company
|
$
|
122.1
|
|
|
$
|
116.4
|
|
(Amounts in millions, except share data)
|
March 31,
2018 |
|
December 31,
2017 |
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
1,038.2
|
|
|
$
|
1,141.5
|
|
Short-term investments
|
147.8
|
|
|
0.6
|
|
||
Accounts receivable, less allowance for doubtful accounts of $9.2 in 2018 and $9.4 in 2017
|
716.8
|
|
|
669.2
|
|
||
Inventories:
|
|
|
|
||||
Finished products
|
162.6
|
|
|
149.2
|
|
||
Products in process
|
42.5
|
|
|
31.2
|
|
||
Raw materials
|
148.6
|
|
|
141.0
|
|
||
Income tax receivable
|
8.1
|
|
|
7.5
|
|
||
Guaranteed notes receivable
|
52.6
|
|
|
39.7
|
|
||
Investments in repurchase agreements
|
110.6
|
|
|
137.5
|
|
||
Other current assets
|
92.7
|
|
|
76.8
|
|
||
Total current assets
|
2,520.5
|
|
|
2,394.2
|
|
||
Property, plant and equipment, net
|
542.3
|
|
|
522.3
|
|
||
Goodwill
|
824.0
|
|
|
834.7
|
|
||
Deferred tax assets
|
224.4
|
|
|
211.1
|
|
||
Investments in unconsolidated joint ventures
|
7.8
|
|
|
6.5
|
|
||
Intangible assets, net
|
272.6
|
|
|
266.6
|
|
||
Other assets
|
80.2
|
|
|
88.0
|
|
||
TOTAL ASSETS
|
$
|
4,471.8
|
|
|
$
|
4,323.4
|
|
LIABILITIES AND EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Loans payable to banks
|
$
|
0.3
|
|
|
$
|
386.5
|
|
Accounts payable
|
274.6
|
|
|
258.1
|
|
||
Accrued payroll
|
134.4
|
|
|
130.4
|
|
||
Current portion of warranties
|
32.1
|
|
|
29.5
|
|
||
VAT payable
|
20.8
|
|
|
18.2
|
|
||
Accrued expenses
|
84.3
|
|
|
81.6
|
|
||
Promotion and customer incentives
|
21.4
|
|
|
24.3
|
|
||
Accrued income tax
|
64.5
|
|
|
56.2
|
|
||
Other accrued liabilities
|
90.5
|
|
|
88.5
|
|
||
Total current liabilities
|
722.9
|
|
|
1,073.3
|
|
||
Long-term debt
|
1,405.4
|
|
|
1,023.3
|
|
||
Pension and post-retirement benefits
|
723.1
|
|
|
700.7
|
|
||
Deferred tax liabilities
|
79.9
|
|
|
75.3
|
|
||
Long-term income tax liabilities
|
169.5
|
|
|
166.8
|
|
||
Other liabilities
|
69.2
|
|
|
82.9
|
|
||
TOTAL LIABILITIES
|
3,170.0
|
|
|
3,122.3
|
|
||
Shareholders’ equity:
|
|
|
|
||||
Preferred stock, 4,000,000 shares authorized; none issued and outstanding
|
—
|
|
|
—
|
|
||
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued: 78,997,751 in 2018; 78,937,828 in 2017; and shares outstanding: 53,596,522 in 2018; 53,735,486 in 2017
|
0.8
|
|
|
0.8
|
|
||
Capital surplus
|
883.2
|
|
|
883.2
|
|
||
Treasury stock, at cost: 25,401,229 shares in 2018; 25,202,342 shares in 2017
|
(1,890.3
|
)
|
|
(1,861.3
|
)
|
||
Retained earnings
|
2,667.8
|
|
|
2,563.2
|
|
||
Accumulated other comprehensive loss
|
(443.1
|
)
|
|
(464.5
|
)
|
||
Total shareholders’ equity
|
1,218.4
|
|
|
1,121.4
|
|
||
Noncontrolling interests
|
83.4
|
|
|
79.7
|
|
||
Total equity
|
1,301.8
|
|
|
1,201.1
|
|
||
TOTAL LIABILITIES AND EQUITY
|
$
|
4,471.8
|
|
|
$
|
4,323.4
|
|
|
Three Months Ended
March 31, |
||||||
(Amounts in millions)
|
2018
|
|
2017
|
||||
Operating activities:
|
|
|
|
||||
Net income including noncontrolling interests
|
$
|
106.7
|
|
|
$
|
84.3
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation
|
24.4
|
|
|
19.4
|
|
||
Amortization of intangibles
|
7.0
|
|
|
5.2
|
|
||
Equity in earnings of unconsolidated joint ventures, net of dividends received
|
(1.2
|
)
|
|
2.2
|
|
||
Non-cash stock compensation
|
4.4
|
|
|
3.5
|
|
||
Non-cash interest expense and debt issuance cost amortization
|
6.0
|
|
|
5.4
|
|
||
Deferred income tax benefit
|
(0.4
|
)
|
|
(6.1
|
)
|
||
Pension and post-retirement benefit expense
|
16.4
|
|
|
15.9
|
|
||
Foreign currency effects on changes in monetary assets/liabilities
|
8.5
|
|
|
(3.1
|
)
|
||
Unrealized loss/(gain) on revaluation of foreign currency forward contracts
|
3.6
|
|
|
(0.5
|
)
|
||
Other
|
0.3
|
|
|
(0.5
|
)
|
||
Changes in assets and liabilities:
|
|
|
|
||||
Accounts receivable, net
|
(33.1
|
)
|
|
(52.7
|
)
|
||
Inventories, net
|
(25.7
|
)
|
|
(18.2
|
)
|
||
Accounts payable
|
12.9
|
|
|
29.2
|
|
||
Other accrued liabilities and taxes
|
2.8
|
|
|
(14.3
|
)
|
||
Other current and long-term assets
|
(23.6
|
)
|
|
(5.5
|
)
|
||
Other long-term liabilities
|
(13.3
|
)
|
|
(4.7
|
)
|
||
Pension and post-retirement benefit contributions
|
(6.7
|
)
|
|
(5.2
|
)
|
||
Net cash provided by operating activities
|
89.0
|
|
|
54.3
|
|
||
Investing activities:
|
|
|
|
||||
Purchases of property, plant and equipment
|
(19.3
|
)
|
|
(13.3
|
)
|
||
Investments in capitalized software
|
(2.0
|
)
|
|
(1.1
|
)
|
||
Purchases of short-term investments and repurchase agreements
|
(174.6
|
)
|
|
(209.7
|
)
|
||
Sales and maturities of short-term investments and repurchase agreements
|
58.1
|
|
|
154.8
|
|
||
Acquisitions of businesses
|
(6.4
|
)
|
|
—
|
|
||
Net cash used in investing activities
|
(144.2
|
)
|
|
(69.3
|
)
|
||
Financing activities:
|
|
|
|
||||
Borrowings of long-term debt
|
368.5
|
|
|
0.3
|
|
||
Net repayments of short-term debt
|
(398.9
|
)
|
|
—
|
|
||
Purchases of treasury stock
|
(30.7
|
)
|
|
(59.7
|
)
|
||
Taxes withheld and paid on employee stock award vestings
|
(4.6
|
)
|
|
(4.2
|
)
|
||
Dividends to noncontrolling interest holders
|
(1.2
|
)
|
|
(1.8
|
)
|
||
Proceeds from exercise of stock options
|
0.4
|
|
|
3.5
|
|
||
Net cash used in financing activities
|
(66.5
|
)
|
|
(61.9
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
18.4
|
|
|
15.4
|
|
||
Net decrease in cash and cash equivalents
|
(103.3
|
)
|
|
(61.5
|
)
|
||
Cash and cash equivalents at beginning of period
|
1,141.5
|
|
|
862.5
|
|
||
Cash and cash equivalents at end of period
|
$
|
1,038.2
|
|
|
$
|
801.0
|
|
Cash paid during the period for:
|
|
|
|
||||
Interest
|
$
|
10.9
|
|
|
$
|
7.6
|
|
Income taxes
|
$
|
15.8
|
|
|
$
|
13.8
|
|
Non cash activity:
|
|
|
|
||||
Change in capital expenditures included in accounts payable and other accrued liabilities
|
$
|
0.2
|
|
|
$
|
1.3
|
|
NOTE 1.
|
Basis of Financial Statement Presentation
|
NOTE 2.
|
Recently Issued Accounting Standards
|
NOTE 3.
|
Revenue from Contracts with Customers
|
|
|
Three Months Ended
March 31, |
||||||
(Amount in millions)
|
|
2018
|
|
2017
|
||||
OEM
(1)
|
|
$
|
766.3
|
|
|
$
|
570.1
|
|
Aftermarket
|
|
237.0
|
|
|
177.2
|
|
||
Total sales
|
|
$
|
1,003.3
|
|
|
$
|
747.3
|
|
(1)
|
Sales for the three-month period ended
March 31, 2017
includes sales made to our Meritor WABCO joint venture which was subsequently acquired and consolidated in the fourth quarter of 2017.
|
|
|
Three Months Ended
March 31, |
||||||
(Amount in millions)
|
|
2018
|
|
2017
|
||||
United States
|
|
$
|
211.1
|
|
|
$
|
104.7
|
|
Europe
|
|
500.8
|
|
|
407.6
|
|
||
Other
(1)
|
|
291.4
|
|
|
235.0
|
|
||
Total sales
|
|
$
|
1,003.3
|
|
|
$
|
747.3
|
|
(1)
|
Sales to other regions includes revenues primarily from Japan, China, Brazil and India.
|
|
Three Months Ended
March 31, |
||||||
(Amount in millions)
|
2018
|
|
2017
|
||||
Foreign currency translation adjustments
:
|
|
|
|
||||
Balance at beginning of period
|
$
|
(177.6
|
)
|
|
$
|
(328.7
|
)
|
Adjustment for the period
|
24.8
|
|
|
33.8
|
|
||
Balance at end of period
(1)
|
(152.8
|
)
|
|
(294.9
|
)
|
||
|
|
|
|
||||
Losses on intra-entity transactions:
|
|
|
|
||||
Balance at beginning of period
|
(11.8
|
)
|
|
(11.4
|
)
|
||
Adjustment for the period
(2)
|
(0.1
|
)
|
|
—
|
|
||
Balance at end of period
|
(11.9
|
)
|
|
(11.4
|
)
|
||
|
|
|
|
||||
Unrealized gains on investments:
|
|
|
|
||||
Balance at beginning of period
|
0.1
|
|
|
0.2
|
|
||
Adjustment for the period
(3)
|
(0.1
|
)
|
|
—
|
|
||
Balance at end of period
|
—
|
|
|
0.2
|
|
||
|
|
|
|
||||
Unrealized losses on hedges:
|
|
|
|
||||
Balance at beginning of period
|
(0.8
|
)
|
|
(1.0
|
)
|
||
Adjustment for the period
|
—
|
|
|
—
|
|
||
Balance at end of period
|
(0.8
|
)
|
|
(1.0
|
)
|
||
|
|
|
|
||||
Pension and post-retirement plans:
|
|
|
|
||||
Balance at beginning of period
|
(274.4
|
)
|
|
(236.4
|
)
|
||
Other comprehensive loss before reclassifications
|
(7.8
|
)
|
|
(3.7
|
)
|
||
Amounts reclassified to earnings, net
(4)
|
4.6
|
|
|
5.6
|
|
||
Balance at end of period
|
$
|
(277.6
|
)
|
|
$
|
(234.5
|
)
|
|
|
|
|
||||
Accumulated other comprehensive loss at end of period
|
$
|
(443.1
|
)
|
|
$
|
(541.6
|
)
|
(2)
|
Relates to intra-entity foreign currency transactions that are of a long term investment nature, when the entities to the transaction are consolidated, combined or accounted for by the equity method in the Company's financial statements.
|
(4)
|
Consists of amortization of prior service cost and actuarial losses that are included as a component of pension and post-retirement expense within other non-operating expenses. The amounts reclassified to earnings are recorded net of tax of
$1.9 million
and
$1.7 million
for three month periods ended
March 31, 2018
and
2017
, respectively.
|
|
Three Months Ended
March 31, |
||||
|
2018
|
|
2017
|
||
Weighted average incremental shares included
|
149,700
|
|
|
214,265
|
|
Shares excluded due to anti-dilutive effect
|
—
|
|
|
29,118
|
|
|
Three Months Ended March 31,
|
||||||||||||||||
|
2018
|
|
2017
|
||||||||||||||
|
Total Shares
|
|
Treasury Stock
|
|
Net Shares
Outstanding
|
|
Total Shares
|
|
Treasury Stock
|
|
Net Shares
Outstanding
|
||||||
Balance at beginning of period
|
78,937,828
|
|
|
(25,202,342
|
)
|
|
53,735,486
|
|
|
78,701,273
|
|
|
(24,209,355
|
)
|
|
54,491,918
|
|
Shares issued upon exercise of stock options
|
6,742
|
|
|
9,092
|
|
|
15,834
|
|
|
62,208
|
|
|
17,632
|
|
|
79,840
|
|
Shares issued upon vesting of RSUs
|
32,503
|
|
|
7,012
|
|
|
39,515
|
|
|
35,547
|
|
|
2,429
|
|
|
37,976
|
|
Shares issued upon vesting of PSUs
|
20,678
|
|
|
6,009
|
|
|
26,687
|
|
|
24,362
|
|
|
7,262
|
|
|
31,624
|
|
Shares purchased for treasury
|
—
|
|
|
(221,000
|
)
|
|
(221,000
|
)
|
|
—
|
|
|
(538,000
|
)
|
|
(538,000
|
)
|
Balance at end of period
|
78,997,751
|
|
|
(25,401,229
|
)
|
|
53,596,522
|
|
|
78,823,390
|
|
|
(24,720,032
|
)
|
|
54,103,358
|
|
|
Three Months Ended
March 31, |
||||||
(Amount in millions)
|
2018
|
|
2017
|
||||
Stock-based compensation
|
$
|
4.4
|
|
|
$
|
3.5
|
|
|
Three Months
Ended March 31, 2018 |
|
Three Months
Ended March 31, 2017 |
||||||||||
|
Underlying
Shares
|
|
Weighted
Average
Grant Date
Fair Value
|
|
Underlying
Shares
|
|
Weighted
Average
Grant Date
Fair Value
|
||||||
RSUs Granted
|
56,710
|
|
|
$
|
140.80
|
|
|
69,012
|
|
|
$
|
114.78
|
|
PSUs Granted
|
54,437
|
|
|
$
|
140.71
|
|
|
69,012
|
|
|
$
|
116.41
|
|
Total Awards
|
111,147
|
|
|
|
|
138,024
|
|
|
|
|
Three Months Ended
March 31, |
||||
|
2018
|
|
2017
|
||
Vest in equal annual installments over three years
|
54,619
|
|
|
69,012
|
|
Vest after three years
|
2,091
|
|
|
—
|
|
Total RSUs granted
|
56,710
|
|
|
69,012
|
|
(Amounts in millions)
|
Face value
|
|
Coupon
|
Maturity date
|
||
Fixed rate term loan - Series A
|
€
|
10.0
|
|
|
0.85%
|
March 31, 2021
|
Fixed rate term loan - Series B
|
60.0
|
|
|
1.15%
|
March 31, 2022
|
|
Fixed rate term loan - Series C
|
80.0
|
|
|
1.43%
|
March 31, 2023
|
|
Floating rate term loan - Series A
|
50.0
|
|
|
6-month EURIBOR plus 80 bps
|
March 31, 2021
|
|
Floating rate term loan - Series B
|
60.0
|
|
|
6-month EURIBOR plus 90 bps
|
March 31, 2022
|
|
Floating rate term loan - Series C
|
40.0
|
|
|
6-month EURIBOR plus 100 bps
|
March 31, 2023
|
|
|
€
|
300.0
|
|
|
|
|
(Amounts in millions)
|
Face value
|
|
Coupon
|
|
Maturity date
|
|||
Series D Notes
|
€
|
190.0
|
|
|
0.84
|
%
|
|
November 15, 2023
|
Series E Notes
|
80.0
|
|
|
1.20
|
%
|
|
November 15, 2026
|
|
Series F Notes
|
170.0
|
|
|
1.36
|
%
|
|
November 15, 2028
|
|
|
€
|
440.0
|
|
|
|
|
|
(Amounts in millions)
|
Face value
|
|
Coupon
|
|
Maturity date
|
|||
Series A Notes
|
$
|
150.0
|
|
|
2.83
|
%
|
|
June 25, 2022
|
Series B Notes
|
200.0
|
|
|
3.08
|
%
|
|
June 25, 2025
|
|
Series C Notes
|
150.0
|
|
|
3.18
|
%
|
|
June 25, 2027
|
|
|
$
|
500.0
|
|
|
|
|
|
(Amounts in millions)
|
As of March 31, 2018
|
|
As of December 31, 2017
|
||||
2014 Facility
|
$
|
—
|
|
|
$
|
82.5
|
|
2015 Facility
|
—
|
|
|
303.6
|
|
||
|
$
|
—
|
|
|
$
|
386.1
|
|
|
|
|
|
||||
Incremental ability to borrow
|
$
|
500.0
|
|
|
$
|
113.9
|
|
(Amounts in millions)
|
|
||
2018
|
$
|
—
|
|
2019
|
0.1
|
|
|
2020
|
0.1
|
|
|
2021
|
73.7
|
|
|
2022
|
297.5
|
|
|
Thereafter
|
1,038.1
|
|
|
Less: unamortized debt issuance fees
|
(4.1
|
)
|
|
Total long-term debt
|
$
|
1,405.4
|
|
|
Three Months Ended
March 31, |
||||||
(Amount in millions)
|
2018
|
|
2017
|
||||
Balance of warranty costs accrued, beginning of period
|
$
|
50.9
|
|
|
$
|
49.3
|
|
Warranty costs accrued
|
11.3
|
|
|
4.5
|
|
||
Warranty claims settled
|
(9.6
|
)
|
|
(5.6
|
)
|
||
Foreign exchange translation effects
|
1.2
|
|
|
0.7
|
|
||
Balance of warranty costs accrued, end of period
|
$
|
53.8
|
|
|
$
|
48.9
|
|
Current liability, included in current portion of warranties
|
$
|
32.1
|
|
|
$
|
31.5
|
|
Long-term liability, included in other liabilities
|
$
|
21.7
|
|
|
$
|
17.4
|
|
|
|
|
|
||||
Warranty costs accrued
|
$
|
11.3
|
|
|
$
|
4.5
|
|
Less: received and anticipated recoveries from suppliers
|
(0.2
|
)
|
|
(0.3
|
)
|
||
Warranty costs net of received and anticipated recoveries
|
$
|
11.1
|
|
|
$
|
4.2
|
|
|
Three Months Ended
March 31, |
||||||
(Amounts in millions)
|
2018
|
|
2017
|
||||
2014 / 2015 Program
|
|
|
|
||||
Balance at beginning of period
|
$
|
16.8
|
|
|
$
|
27.8
|
|
Charges
|
(0.3
|
)
|
|
(0.4
|
)
|
||
Payments
|
(4.9
|
)
|
|
(2.8
|
)
|
||
Foreign exchange effects
|
0.4
|
|
|
0.5
|
|
||
Balance at end of period
|
$
|
12.0
|
|
|
$
|
25.1
|
|
Other Programs
|
|
|
|
||||
Balance at beginning of period
|
$
|
26.9
|
|
|
$
|
23.4
|
|
Charges
|
—
|
|
|
0.3
|
|
||
Payments
|
(2.9
|
)
|
|
(2.8
|
)
|
||
Foreign exchange effects
|
0.8
|
|
|
0.5
|
|
||
Balance at end of period
|
$
|
24.8
|
|
|
$
|
21.4
|
|
Total streamlining liability
|
$
|
36.8
|
|
|
$
|
46.5
|
|
|
Three Months Ended
March 31, |
||||||||||||||
|
2018
|
|
2017
|
||||||||||||
(Amounts in millions)
|
2014/2015 Program
|
|
Other
Programs
|
|
2014/2015 Program
|
|
Other
Programs
|
||||||||
Employee-related charges – cost of sales
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(3.4
|
)
|
|
$
|
0.2
|
|
Employee-related charges – selling and administrative
|
(0.4
|
)
|
|
—
|
|
|
2.9
|
|
|
—
|
|
||||
Other streamlining charges
|
0.1
|
|
|
—
|
|
|
0.1
|
|
|
0.1
|
|
||||
Total program costs
|
$
|
(0.3
|
)
|
|
$
|
—
|
|
|
$
|
(0.4
|
)
|
|
$
|
0.3
|
|
|
Three Months Ended
March 31, |
||||||||||||||
|
2018
|
|
2017
|
||||||||||||
(Amounts in millions)
|
Pension
Benefits
|
|
Health
& Life
Ins.
Benefits
|
|
Pension
Benefits
|
|
Health
& Life
Ins.
Benefits
|
||||||||
Service cost-benefits earned during period
|
$
|
6.8
|
|
|
$
|
0.2
|
|
|
$
|
4.9
|
|
|
$
|
0.2
|
|
Interest cost on the projected benefit obligation
|
4.2
|
|
|
0.1
|
|
|
3.4
|
|
|
0.1
|
|
||||
Less: expected return on plan assets
|
(1.3
|
)
|
|
—
|
|
|
(1.2
|
)
|
|
—
|
|
||||
Amortization of net loss
|
6.3
|
|
|
0.1
|
|
|
8.4
|
|
|
0.1
|
|
||||
Pension and post-retirement benefit plan cost
|
$
|
16.0
|
|
|
$
|
0.4
|
|
|
$
|
15.5
|
|
|
$
|
0.4
|
|
(Amounts in millions)
|
|
|
|
|
|
As of March 31, 2018
|
|
As of December 31, 2017
|
||||||||||
Foreign Currency
|
|
Unit of Measure
|
|
Hedged against
|
|
Quantity Hedged
|
|
Notional Amount (USD Equivalent)
|
|
Quantity Hedged
|
|
Notional Amount (USD Equivalent)
|
||||||
Chinese Yuan
|
|
CNY
|
|
EUR
|
|
411.5
|
|
|
$
|
65.4
|
|
|
550.0
|
|
|
$
|
84.2
|
|
US Dollar
|
|
USD
|
|
EUR
|
|
305.3
|
|
|
305.3
|
|
|
294.2
|
|
|
294.2
|
|
||
Hong Kong Dollar
|
|
HKD
|
|
EUR
|
|
285.0
|
|
|
36.3
|
|
|
250.0
|
|
|
32.0
|
|
||
Polish Zloty
|
|
PLN
|
|
EUR
|
|
72.0
|
|
|
21.0
|
|
|
64.0
|
|
|
18.3
|
|
||
British Pound
|
|
GBP
|
|
EUR
|
|
11.6
|
|
|
16.3
|
|
|
9.5
|
|
|
12.8
|
|
(Amounts in millions)
|
|
||
Accounts receivable
|
$
|
1.8
|
|
Inventory
|
1.4
|
|
|
Other current assets
|
0.3
|
|
|
Property, plant & equipment
|
1.1
|
|
|
Intangible assets
|
7.3
|
|
|
Total liabilities assumed
|
(1.4
|
)
|
|
Identifiable net assets
|
$
|
10.5
|
|
Goodwill
|
4.5
|
|
|
Total estimated fair value of net assets
|
$
|
15.0
|
|
Less: fair value of equity method investment
|
(7.1
|
)
|
|
Net purchase consideration
|
$
|
7.9
|
|
(Amounts in millions)
|
|
||
Cash & cash equivalents
|
$
|
16.4
|
|
Accounts receivable
|
38.6
|
|
|
Inventory
|
44.1
|
|
|
Other current assets
|
0.1
|
|
|
Property, plant & equipment
|
2.1
|
|
|
Intangible assets
|
165.2
|
|
|
Accounts payable assumed
|
(56.2
|
)
|
|
Accrued liabilities assumed
|
(17.5
|
)
|
|
Identifiable net assets acquired
|
$
|
192.8
|
|
Goodwill
|
320.5
|
|
|
Total fair value of net assets
|
513.3
|
|
|
Less: fair value of equity method investment
|
$
|
(258.0
|
)
|
Less: elimination of unrealized profits on inventory
|
(5.3
|
)
|
|
Net purchase consideration
|
$
|
250.0
|
|
|
March 31, 2018
|
|||||||||||||||
(Amounts in millions)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|||||||||
Short-term investments
(a)
|
$
|
—
|
|
|
$
|
147.8
|
|
|
$
|
—
|
|
|
$
|
147.8
|
|
|
Foreign currency derivative assets
(b)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Foreign currency derivative liabilities
(b)
|
—
|
|
|
1.5
|
|
|
—
|
|
|
1.5
|
|
|||||
|
|
|
|
|
|
|
|
|||||||||
|
December 31, 2017
|
|||||||||||||||
(Amounts in millions)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|||||||||
Short-term investments
(a)
|
$
|
—
|
|
|
$
|
0.6
|
|
|
$
|
—
|
|
9.0
|
|
$
|
0.6
|
|
Foreign currency derivative assets
(b)
|
—
|
|
|
2.0
|
|
|
—
|
|
|
2.0
|
|
|||||
Foreign currency derivative liabilities
(b)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
(a)
|
Short-term investments consist of mutual funds or deposit funds holding primarily term deposits, certificates of deposit and short-term bonds. The fair value of short-term investments is determined based on pricing sources for identical instruments in less active markets. The amount of unrealized loss recognized in the condensed consolidated statement of operations for the three-month period ended
March 31, 2018
related to short-term investments still held as of this date was immaterial.
|
(b)
|
Fair value of derivative instruments determined based on Level 2 inputs including credit ratings and other criteria observable in the market.
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
Three Months Ended
March 31, |
|
Excluding foreign
exchange translation *
|
||||||||||||||
(Amounts in millions)
|
2018
|
|
2017
|
|
% change
reported
|
|
2018
adjusted
amount
|
|
% change
adjusted
|
||||||||
Sales
|
$
|
1,003.3
|
|
|
$
|
747.3
|
|
|
34.3
|
%
|
|
$
|
918.6
|
|
|
22.9
|
%
|
Cost of sales
|
694.3
|
|
|
507.1
|
|
|
36.9
|
%
|
|
640.4
|
|
|
26.3
|
%
|
|||
Gross profit
|
309.0
|
|
|
240.2
|
|
|
28.6
|
%
|
|
278.2
|
|
|
15.8
|
%
|
|||
|
|
|
|
|
|
|
|
|
|
||||||||
Operating expenses
|
162.0
|
|
|
131.7
|
|
|
23.0
|
%
|
|
145.7
|
|
|
10.6
|
%
|
|||
Equity income of unconsolidated joint ventures
|
0.4
|
|
|
5.7
|
|
|
(93.0
|
)%
|
|
0.4
|
|
|
(93.0
|
)%
|
|||
Income tax expense
|
26.3
|
|
|
15.3
|
|
|
71.9
|
%
|
|
25.0
|
|
|
63.4
|
%
|
*
|
Amounts translated using average exchange rates for the three month period ending
March 31, 2017
|
(Amounts in millions)
|
Cost of Sales
|
|
Gross Profit
|
||||
Cost of sales / gross profit for the three months ended March 31, 2017
|
$
|
507.1
|
|
|
$
|
240.2
|
|
|
|
|
|
||||
Increase/(decrease) due to:
|
|
|
|
||||
Sales price reductions
|
—
|
|
|
(15.4
|
)
|
||
Sales price reductions as % of sales
|
|
|
(1.8
|
)%
|
|||
Volume, mix and absorption
|
88.3
|
|
|
26.8
|
|
||
Material productivity
(1)
|
(16.5
|
)
|
|
16.5
|
|
||
Conversion productivity
|
(9.0
|
)
|
|
9.0
|
|
||
U.S. acquisitions
|
49.3
|
|
|
22.2
|
|
||
Labor inflation
|
4.1
|
|
|
(4.1
|
)
|
||
Streamlining costs
|
3.0
|
|
|
(3.0
|
)
|
||
Foreign exchange effects
(2)
|
64.8
|
|
|
20.0
|
|
||
Other
|
3.2
|
|
|
(3.2
|
)
|
||
Net increase
|
187.2
|
|
|
68.8
|
|
||
|
|
|
|
||||
Cost of sales / gross profit for the three months ended March 31, 2018
|
$
|
694.3
|
|
|
$
|
309.0
|
|
(Amounts in millions)
|
|
||
Operating expenses for the three months ended March 31, 2017
|
$
|
131.7
|
|
|
|
||
Increase/(decrease) due to:
|
|
||
Labor inflation
|
3.8
|
|
|
Incremental costs from U.S. acquisitions
(1)
|
11.9
|
|
|
Streamlining expenses
|
(3.2
|
)
|
|
Foreign exchange translation
|
16.3
|
|
|
Employee related costs
|
0.9
|
|
|
Other
(2)
|
0.6
|
|
|
Net increase
|
30.3
|
|
|
|
|
||
Operating expenses for the three months ended March 31, 2018
|
$
|
162.0
|
|
|
Three Months Ended March 31,
|
||||||||||||||||||||||
|
2018
|
|
2017
|
||||||||||||||||||||
(Amounts in millions)
|
Repurchase Agreements
|
|
Short-term Investments
|
|
Total
|
|
Repurchase Agreements
|
|
Short-term Investments
|
|
Total
|
||||||||||||
Investments
|
$
|
—
|
|
|
$
|
174.6
|
|
|
$
|
174.6
|
|
|
$
|
156.5
|
|
|
$
|
53.2
|
|
|
$
|
209.7
|
|
Sales and redemptions
|
30.5
|
|
|
27.6
|
|
|
58.1
|
|
|
154.8
|
|
|
—
|
|
|
154.8
|
|
||||||
Net cash received/(invested)
|
$
|
30.5
|
|
|
$
|
(147.0
|
)
|
|
$
|
(116.5
|
)
|
|
$
|
(1.7
|
)
|
|
$
|
(53.2
|
)
|
|
$
|
(54.9
|
)
|
(Amounts in millions)
|
Face value
|
|
Coupon
|
Maturity date
|
||
Fixed rate term loan - Series A
|
€
|
10.0
|
|
|
0.85%
|
March 31, 2021
|
Fixed rate term loan - Series B
|
60.0
|
|
|
1.15%
|
March 31, 2022
|
|
Fixed rate term loan - Series C
|
80.0
|
|
|
1.43%
|
March 31, 2023
|
|
Floating rate term loan - Series A
|
50.0
|
|
|
6-month EURIBOR plus 80 bps
|
March 31, 2021
|
|
Floating rate term loan - Series B
|
60.0
|
|
|
6-month EURIBOR plus 90 bps
|
March 31, 2022
|
|
Floating rate term loan - Series C
|
40.0
|
|
|
6-month EURIBOR plus 100 bps
|
March 31, 2023
|
|
|
€
|
300.0
|
|
|
|
|
•
|
the actual level of commercial vehicle production in our end-markets;
|
•
|
adverse developments in the business of our key customers;
|
•
|
periodic changes to contingent liabilities;
|
•
|
adverse developments in general business, economic and political conditions or any outbreak or escalation of hostilities on a national, regional or international basis;
|
•
|
changes in international or U.S. economic conditions, such as inflation, interest rate fluctuations, foreign exchange rate fluctuations or recessions in our markets;
|
•
|
unpredictable difficulties or delays in the development of new product technology;
|
•
|
pricing changes to our products or those of our competitors, and other competitive pressures on pricing and sales;
|
•
|
our ability to receive components and parts from our suppliers of a reasonable quality level or to obtain them at reasonable price levels due to fluctuations in the costs of the underlying raw materials;
|
•
|
our ability to access credit markets or capital markets on a favorable basis or at all;
|
•
|
our ability to service our debt obligations;
|
•
|
changes in the environmental regulations that affect our current and future products;
|
•
|
competition in our existing and future lines of business and the financial resources of competitors;
|
•
|
our failure to comply with regulations and any changes in regulations;
|
•
|
our failure to complete potential future acquisitions, collaborations and cooperations or to realize benefits from completed acquisitions, collaborations and cooperations;
|
•
|
our inability to implement our growth plan;
|
•
|
our ability to service our pension obligations;
|
•
|
the loss of any of our senior management;
|
•
|
difficulties in obtaining or retaining the management and other human resource competencies that we need to achieve our business objectives;
|
•
|
the success of, and costs and savings associated with, our current streamlining initiatives;
|
•
|
labor relations;
|
•
|
our ability to mitigate any tax risks, including, but not limited to those risks associated with changes in legislation, tax audits and the loss of the benefits associated with our tax rulings and incentives in certain jurisdictions;
|
•
|
risks inherent in operating in foreign countries, including exposure to local economic conditions, government regulation, currency restrictions and other restraints, changes in tax laws and rulings, expropriation, political instability and diminished ability to legally enforce our contractual rights;
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
Item 4.
|
Controls and Procedures
|
Item 1.
|
Legal Proceedings
|
Item 1A.
|
Risk Factors
|
Period
|
|
Total Number of Shares Purchased (a)
|
Average price Paid per Share
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (a)
|
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (a)
|
||
|
|
|
|
|
|
||
Total through December 31, 2017
|
|
1,033,000
|
|
$116.13
|
1,033,000
|
|
$480,041,067
|
|
|
|
|
|
|
||
January 1 - January 31
|
|
—
|
|
-
|
—
|
|
$480,041,067
|
February 1 - February 28
|
|
—
|
|
-
|
—
|
|
$480,041,067
|
March 1 - March 31
|
|
221,000
|
|
$138.74
|
221,000
|
|
$449,378,909
|
Total first quarter
|
|
221,000
|
|
-
|
221,000
|
|
$449,378,909
|
|
|
|
|
|
|
||
Total through March 31, 2018
|
|
1,254,000
|
|
$120.11
|
1,254,000
|
|
$449,378,909
|
(a)
|
Relates to the approved share repurchase program as discussed above.
|
Item 6.
|
Exhibits
|
Exhibit
No.
|
Description
|
||
10.1
|
|
||
10.2
|
|||
10.3
|
Promissory Loan Agreement in the principal amount of €10 million, dated March 22, 2018, among WABCO Europe BVBA, UniCredit Bank AG, and WABCO Holdings Inc. (previously filed as Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 001-33332), filed on March 28, 2018 and incorporated herein by reference).
|
||
10.4
|
Promissory Loan Agreement in the principal amount of €40 million, dated March 22, 2018, among WABCO Europe BVBA, UniCredit Bank AG, and WABCO Holdings Inc. (previously filed as Exhibit 10.2 to the Company's Current Report on Form 8-K (File No. 001-33332), filed on March 28, 2018 and incorporated herein by reference).
|
||
10.5
|
Promissory Loan Agreement in the principal amount of €50 million, dated March 22, 2018, among WABCO Europe BVBA, UniCredit Bank AG, and WABCO Holdings Inc. (previously filed as Exhibit 10.3 to the Company's Current Report on Form 8-K (File No. 001-33332), filed on March 28, 2018 and incorporated herein by reference).
|
||
10.6
|
Promissory Loan Agreement in the principal amount of €60 million, dated March 22, 2018, among WABCO Europe BVBA, UniCredit Bank AG, and WABCO Holdings Inc. (previously filed as Exhibit 10.4 to the Company's Current Report on Form 8-K (File No. 001-33332), filed on March 28, 2018 and incorporated herein by reference).
|
||
10.7
|
Promissory Loan Agreement in the principal amount of €60 million, dated March 22, 2018, among WABCO Europe BVBA, UniCredit Bank AG, and WABCO Holdings Inc. (previously filed as Exhibit 10.5 to the Company's Current Report on Form 8-K (File No. 001-33332), filed on March 28, 2018 and incorporated herein by reference).
|
||
10.8
|
Promissory Loan Agreement in the principal amount of €80 million, dated March 22, 2018, among WABCO Europe BVBA, UniCredit Bank AG, and WABCO Holdings Inc. (previously filed as Exhibit 10.6 to the Company's Current Report on Form 8-K (File No. 001-33332), filed on March 28, 2018 and incorporated herein by reference).
|
||
31.1
|
|||
31.2
|
|||
32.1
|
|||
32.2
|
|||
101
|
The following financial information from WABCO Holdings Inc.'s Quarterly Report on Form 10-Q for the period ended March 31, 2018, filed with the SEC on April 19, 2018, formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.
|
|
WABCO HOLDINGS INC.
|
|
/
S
/ SEAN DEASON
|
Sean Deason
|
Vice President Controller and Investor Relations
|
(Principal Accounting Officer)
|
1.
|
I have reviewed this quarterly report on Form 10-Q of WABCO Holdings Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
/s/ Jacques Esculier
|
Jacques Esculier
|
Chief Executive Officer and Chairman of the Board
|
1.
|
I have reviewed this quarterly report on Form 10-Q of WABCO Holdings Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
/s/ Alexander De Bock
|
Alexander De Bock
|
Interim Chief Financial Officer
|
(i)
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(ii)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the periods covered in the Report.
|
/s/ Jacques Esculier
|
Jacques Esculier
|
Chief Executive Officer and Chairman of the Board
|
(i)
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(ii)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the periods covered in the Report.
|
/s/ Alexander De Bock
|
Alexander De Bock
|
Interim Chief Financial Officer
|